Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Reconstruction and Computational Modelling for Inherited Metabolic Diseases

Project description

Personalised computational models for disease diagnosis

Inherited metabolic diseases are rare and often difficult to diagnose and manage. Advances in genomics, proteomics, and computational modelling now offer new opportunities to personalise diagnosis and treatment. The EU-funded Recon4IMD project harnesses these tools to build patient-specific computational models integrating genomic, transcriptomic, proteomic, and metabolomic data. These models will be trained on data from 2 000 diagnosed patients and validated in undiagnosed cases. Gaucher disease will serve as an example for understanding disease severity mechanisms. Personalised modelling software will be designed to be clinically accessible and regulatory-compliant, paving the way towards precision medicine for rare metabolic diseases.

Objective

Our overall objectives are to accelerate the diagnosis, and enable personalised management, of inherited metabolic diseases (IMDs). Established academic technology for statistical genomic analysis, deep learning-based prediction of protein structure, and whole-body metabolic network modelling shall be applied to generate personalised computational models, given patient-derived genomic, transcriptomic, proteomic and metabolomic data. To train diagnostic models, a comprehensive clinical team will recruit 1,945 diagnosed patients with a wide variety of IMDs, then validate the clinical utility of personalised computational models on a set of 685 undiagnosed patients. An enhanced human metabolic network reconstruction, especially for lipid metabolism, reaction kinetics and inherited metabolic disease pathways, will increase the predictive capacity of cellular and whole-body metabolic network models. As an exemplar for other IMDs, personalised computational modelling will be used to identify compensatory and aggravating mechanisms that associate with clinical severity in Gaucher disease. The predictive capacity of personalised models will be validated by comparison with additional empirical investigations of protein structure and function as well as metabolomics, tracer-based metabolomics and proteomics of patient-derived in vitro disease models. To maximise the potential for impact, personalised modelling software will be developed to be generally applicable to a broad variety of IMDs, and implemented in a way that is both accessible to clinicians and admissible to regulatory authorities. Sustainability will be promoted by development of a roadmap for a European foundation to aid personalised diagnosis and management of IMDs, informed by broad stakeholder consultation. This is a unique opportunity to realise the potential of personalised computational modelling for a broad set of rare diseases, which is a field where European collaboration is an essential for progress.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-RIA - HORIZON Research and Innovation Actions

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-HLTH-2022-TOOL-12-two-stage

See all projects funded under this call

Coordinator

UNIVERSITY OF GALWAY
Net EU contribution
€ 2 694 512,75
Address
UNIVERSITY ROAD
H91 Galway
Ireland
Region
Ireland Northern and Western West
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 2 694 512,75

Participants (36)

Partners (5)